EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

The use of ketamine as an antidepressant: a systematic review and meta‐analysis

Caoimhe M Coyle, Keith R Laws

Human Psychopharmacology: Clinical and Experimental · 2015-05 · 30 (3) · 152-163

DOI: 10.1002/hup.2475 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, online erschienen am 07.04.2015. Verfasst von Caoimhe M Coyle und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK. Die Arbeit wurde bisher 262-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The current meta‐analysis examines the effects of ketamine infusion on depressive symptoms over time in major depressive disorder (MDD) and bipolar disorder (BD).

Methods

Following a systematic review of the literature, data were extracted from 21 studies ( n = 437 receiving ketamine) and analysed at four post‐infusion time points (4 h, 24 h, 7 days and 12–14 days). The moderating effects of several factors were assessed including: repeat/single infusion, diagnosis, open‐label/participant‐blind infusion, pre–post/placebo‐controlled design and the sex of patients.

Results

Effect sizes were significantly larger for repeat than single infusion at 4 h, 24 h and 7 days. For single infusion studies, effect sizes were large and significant at 4 h, 24 h and 7 days. The percentage of males was a predictor of antidepressant response at 7 days. Effect sizes for open‐label and participant‐blind infusions were not significantly different at any time point.

Conclusions

Single ketamine infusions elicit a significant antidepressant effect from 4 h to 7 days; the small number of studies at 12–14 days post infusion failed to reach significance. Results suggest a discrepancy in peak response time depending upon primary diagnosis — 24 h for MDD and 7 days for BD. The majority of published studies have used pre–post comparison; further placebo‐controlled studies would help to clarify the effect of ketamine over time. Copyright © 2015 John Wiley & Sons, Ltd.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsBipolar DisorderMajor Depressive DisorderExcitatory Amino Acid AntagonistsFemaleHumansInfusions, IntravenousKetamineMaleSex FactorsTime Factors

Stichwörter der Autor:innen

bipolar disorderdepressionketaminemajor depressive disorder

Substanzen

Antidepressive AgentsExcitatory Amino Acid AntagonistsKetamine

Autor:innen und Institutionen

  • School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.

Zitieren

APA

Coyle, C. M., & Laws, K. R. (2015). The use of ketamine as an antidepressant: a systematic review and meta‐analysis. Human Psychopharmacology: Clinical and Experimental, 30(3), 152-163. https://doi.org/10.1002/hup.2475

Vancouver

Coyle CM, Laws KR. The use of ketamine as an antidepressant: a systematic review and meta‐analysis. Human Psychopharmacology: Clinical and Experimental. 2015;30(3):152-163. doi:10.1002/hup.2475

BibTeX
@article{Coyle2015,
  author = {Coyle, Caoimhe M and Laws, Keith R},
  title = {The use of ketamine as an antidepressant: a systematic review and meta‐analysis},
  journal = {Human Psychopharmacology: Clinical and Experimental},
  year = {2015},
  volume = {30},
  number = {3},
  pages = {152--163},
  doi = {10.1002/hup.2475}
}
Kostenlos starten →